Cargando…

Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis

Cystic fibrosis (CF) is a life-shortening monogenic disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein, an anion channel that transports chloride and bicarbonate across epithelia. Despite clinical progress in delaying disease progression with s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, Madalena C, Silva, Iris A L, Figueira, Miriam F, Amaral, Margarida D, Lopes-Pacheco, Miquéias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316759/ https://www.ncbi.nlm.nih.gov/pubmed/34326672 http://dx.doi.org/10.2147/JEP.S255377

Ejemplares similares

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias
Publicado: (2016)

Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9
por: Pinto, Madalena C., et al.
Publicado: (2021)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)

Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
por: Silva, Iris A. L., et al.
Publicado: (2022)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
por: Bacalhau, Mafalda, et al.
Publicado: (2023)

Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies
por: Roda, Juliana, et al.
Publicado: (2021)

Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis
por: Reihill, James A., et al.
Publicado: (2021)

Ion channel pharmacology /
Publicado: (1998)

Multi-Ion Mechanism for Ion Permeation and Block in the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel
por: Linsdell, Paul, et al.
Publicado: (1997)

Additive Potentiation of R334W-CFTR Function by Novel Small Molecules
por: Bacalhau, Mafalda, et al.
Publicado: (2023)

Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis
por: Rimessi, Alessandro, et al.
Publicado: (2020)

Assessment of Distinct Electrophysiological Parameters in Rectal Biopsies for the Choice of the Best Diagnosis/Prognosis Biomarkers for Cystic Fibrosis
por: Silva, Iris A. L., et al.
Publicado: (2020)

Small molecule ion channels increase host defenses in cystic fibrosis airway epithelia
por: Muraglia, Katrina A., et al.
Publicado: (2019)

Anion carriers as potential treatments for cystic fibrosis: transport in cystic fibrosis cells, and additivity to channel-targeting drugs
por: Li, Hongyu, et al.
Publicado: (2019)

Integrity and Stability of PTC Bearing CFTR mRNA and Relevance to Future Modulator Therapies in Cystic Fibrosis
por: Clarke, Luka A., et al.
Publicado: (2021)

Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels
por: Miceli, Francesco, et al.
Publicado: (2015)

The K(+) Channel Opener 1-EBIO Potentiates Residual Function of Mutant CFTR in Rectal Biopsies from Cystic Fibrosis Patients
por: Roth, Eva K., et al.
Publicado: (2011)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
por: Veit, Guido, et al.
Publicado: (2022)

Pharmacological inhibitors of the cystic fibrosis transmembrane conductance regulator exert off-target effects on epithelial cation channels
por: Lin, JinHeng, et al.
Publicado: (2022)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020)

Cystic fibrosis transmembrane conductance regulator (CFTR): Making an ion channel out of an active transporter structure
por: Linsdell, Paul
Publicado: (2018)

Impact of KLF4 on Cell Proliferation and Epithelial Differentiation in the Context of Cystic Fibrosis
por: Sousa, Luís, et al.
Publicado: (2020)

New drugs in cystic fibrosis: what has changed in the last decade?
por: Roda, Juliana, et al.
Publicado: (2022)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Mutation-class dependent signatures outweigh disease-associated processes in cystic fibrosis cells
por: Santos, Lúcia, et al.
Publicado: (2023)

Global impact of bronchiectasis and cystic fibrosis
por: Redondo, Margarida, et al.
Publicado: (2016)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
por: Middleton, Peter G., et al.
Publicado: (2023)

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
por: Chaudary, Nauman
Publicado: (2018)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies
por: Marcão, Ana, et al.
Publicado: (2018)

Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target
por: Simões, Filipa B., et al.
Publicado: (2021)

Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
por: Altamura, Concetta, et al.
Publicado: (2021)

Drug Repurposing for Cystic Fibrosis: Identification of Drugs That Induce CFTR-Independent Fluid Secretion in Nasal Organoids
por: Rodenburg, Lisa W., et al.
Publicado: (2022)

CyFi-MAP: an interactive pathway-based resource for cystic fibrosis
por: Pereira, Catarina, et al.
Publicado: (2021)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis
por: Nickolaus, Peter, et al.
Publicado: (2020)

The role of modulators in cystic fibrosis related diabetes
por: Merjaneh, Lina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_88t5s2lrb0m0hhn1e892ataveq